These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 18595710

  • 1. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD, He Y, Chai NN, Toyoda M, Dunn R, Kehry MR, Klein AS, Jordan SC.
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [Abstract] [Full Text] [Related]

  • 2. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G, Briggs D, Cockwell P, Lipkin G, Mjörnstedt L, Mölne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME.
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD3ε induces splenic B220lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization.
    Todo T, Wu G, Chai NN, He Y, Martins G, Gupta A, Fair J, Liu NY, Jordan S, Klein A.
    Int Immunol; 2012 Aug; 24(8):529-38. PubMed ID: 22531063
    [Abstract] [Full Text] [Related]

  • 4. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N, Pirsch J, Samaniego M.
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [Abstract] [Full Text] [Related]

  • 5. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.
    Jordan SC, Vo AA, Toyoda M, Tyan D, Nast CC.
    Pediatr Transplant; 2005 Apr; 9(2):155-61. PubMed ID: 15787786
    [Abstract] [Full Text] [Related]

  • 6. Current approaches to treatment of antibody-mediated rejection.
    Jordan SC, Vo AA, Tyan D, Nast CC, Toyoda M.
    Pediatr Transplant; 2005 Jun; 9(3):408-15. PubMed ID: 15910400
    [Abstract] [Full Text] [Related]

  • 7. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 8. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
    Rashid A, Auchincloss H, Sharon J.
    J Immunol; 1992 Mar 01; 148(5):1382-8. PubMed ID: 1538121
    [Abstract] [Full Text] [Related]

  • 9. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
    Schröder C, Azimzadeh AM, Wu G, Price JO, Atkinson JB, Pierson RN.
    Transpl Immunol; 2003 Mar 01; 12(1):19-28. PubMed ID: 14551029
    [Abstract] [Full Text] [Related]

  • 10. Effect of alloantibodies on corneal allograft survival.
    Hegde S, Mellon JK, Hargrave SL, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 2002 Apr 01; 43(4):1012-8. PubMed ID: 11923241
    [Abstract] [Full Text] [Related]

  • 11. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.
    Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494
    [Abstract] [Full Text] [Related]

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 May 27; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 13. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.
    Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897
    [Abstract] [Full Text] [Related]

  • 14. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X, Tyerman K, Ang A, Koo K, Parameswaran K, Tao K, Mai L, Lang H, West LJ.
    Transplant Proc; 2005 Jan 15; 37(1):29-31. PubMed ID: 15808536
    [Abstract] [Full Text] [Related]

  • 15. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, Appel MC.
    Clin Immunol; 2004 Sep 15; 112(3):273-83. PubMed ID: 15308121
    [Abstract] [Full Text] [Related]

  • 16. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 15; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 17. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L, Conca R, Magistroni P, Leonardi G, Oda A, Rosati F, Leone E, Tacconella M, Roggero S, Segoloni GP, Amoroso A.
    Transpl Immunol; 2008 Jul 15; 19(3-4):238-43. PubMed ID: 18675725
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
    Hori T, Kuribayashi K, Uemoto S, Saito K, Wang L, Torii M, Shibutani S, Taniguchi K, Yagi S, Iida T, Yamamoto C, Kato T.
    Transpl Immunol; 2008 Apr 15; 19(1):45-54. PubMed ID: 18346637
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.